Is Crestchem overvalued or undervalued?

As of 17 November 2025, Crestchem's valuation grade has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued. Key ratios supporting this assessment include a PE ratio of 17.38, an EV to EBITDA ratio of 15.34, and a remarkable ROCE of 30.63%.
In comparison to its peers, Crestchem stands out with a much lower PE ratio than Solar Industries at 95.31 and Gujarat Fluoroch at 57.85, both categorized as very expensive. Additionally, Crestchem's PEG ratio is notably at 0.00, suggesting strong growth potential relative to its price. Despite recent stock performance lagging behind the Sensex, particularly with a year-to-date decline of 58.22% compared to the Sensex's gain of 8.72%, the company's strong fundamentals indicate it is positioned for recovery and growth in the specialty chemicals sector.